Honest Criticisms and Limitations of the Testosterone Trials (T-Trials) Trial
A deep-dive into the enrollment biases, follow-up constraints, generalizability gaps, and statistical caveats of the landmark 2016 Testosterone Trials in older men.
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 8 of 8 clinical reviews.
A deep-dive into the enrollment biases, follow-up constraints, generalizability gaps, and statistical caveats of the landmark 2016 Testosterone Trials in older men.
A deep-dive into the T-Trials design: coordinated multi-trial randomization, endpoint definitions, blinding strategies, and statistical choices that shape how we interpret testosterone gel benefits in older men.
A deep-dive into the health-economic data surrounding the Testosterone Trials (T-Trials), including cost per QALY estimates, payer-coverage patterns, list-price vs net-price realities for testosterone gel, and the relative-value calculation for older men considering TRT.
Deep dive into T-Trials follow-up studies, durability of testosterone gel benefits in older men, TRAVERSE safety data, and long-term cardiovascular outcomes beyond the original 12-month intervention.
A deep-dive into the T-Trials' actual effect sizes, confidence intervals, secondary endpoints, and response distribution for testosterone gel in men 65 and older.
Deep-dive into the T-Trials subgroup analyses examining which older men benefited most from testosterone gel by age, BMI, baseline testosterone, and functional status.
A deep-dive overview of the Testosterone Trials (TTrials), a landmark 2016 NEJM study examining whether testosterone gel improves sexual function, vitality, and physical function in men 65 and older with low testosterone.
How the 2016 T-Trials reshaped TRT prescribing for older men: guideline updates, real-world prescribing shifts, and what clinicians should do differently today.